Afuco™ Anti-Influenza Virus M2e ADCC Therapeutic Antibody (TCN-032), ADCC Enhanced
Anti-M2e ADCC Enhanced Antibody (TCN-032) is an ADCC enhanced antibody produced by our Afuco™ platform. TCN-032 is a human monoclonal antibody targeting a conserved epitope on M2e, was explored in experimental human influenza. TCN-032 may provide immediate immunity and therapeutic benefit in influenza A infection, with no apparent emergence of resistant virus. TCN-032 was safe with no evidence of immune exacerbation based on serum cytokine expression.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-488CL |
| Pricing | Inquiry |
| Host | Human |
| Target | Influenza Virus |
| Species Reactivity | Influenza Virus |
| Type | ADCC enhanced antibody |
| Storage | Store it under sterile conditions at -20°C upon receiving. Recommend to pack the protein into smaller quantities for optimal storage. |